Skip to main content
Caplight Logo









Cordance Medical

Cordance Medical

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://cordancemedical.com/

Last Round

Seed

Nov 24, 2025

Total Funding Raised

$20.85M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cordance Medical is a medical device company developing a non-invasive ultrasound system, the NeuroAccess™ platform, to reversibly open the blood-brain barrier, enabling precision medicine for brain diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

blood-brain barrier openingfocused ultrasoundliquid biopsybrain drug deliveryBBB openingFUSneurotechbrain liquid biopsyneuro-oncologymedical devicemicrobubblestherapeutic deliverybiomarker analysisultrasound contrast agentsbrain tumorsFDA Breakthrough Devicecell-free DNAcfDNA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cordance Medical Comparables

Compare Cordance Medical with similar companies based on industry and business-model similarity.

Cordance Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NaviFUS Corp.
84%
Delsona Therapeutics
83%
Neumous
81%

Cordance Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 24, 2025
GrantSep 19, 2024
Series AFeb 8, 2023
SeedAug 1, 2022
GrantJul 16, 2021
Grant
May 15, 2020

Key People

Founding team and executive leadership

Bhaskar Ramamurthy

Founder CTO

Founding Team

Cordance Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2026

    Open roles increased to 3, 3x the trailing average.

  • Nov 24, 2025

    $8M raised in Seed round.

Cordance Medical Filings

Explore SEC and related filing metadata, where available.

Cordance Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cordance Medical's valuation, stock price, and market status.

Is Cordance Medical a public or private company?

Cordance Medical is a private company.

What is the current stock price of Cordance Medical?

Cordance Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Cordance Medical worth (valuation)?

Valuation information for Cordance Medical is not publicly available.

Can I buy Cordance Medical stock?

Cordance Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cordance Medical's last funding round?

Cordance Medical's most recent funding round was Seed on November 24, 2025.

Who are the main investors in Cordance Medical?

Key investors in Cordance Medical include Sonder Capital.

Will Cordance Medical IPO soon?

No public IPO plans have been announced for Cordance Medical.

How can I track Cordance Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cordance Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMountain View, California
Employee Range10
Year Founded2018
Last FundingNov 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?